Which Hedge Funds Own SYRE — Spyre Therapeutics, Inc. Commo

19 of the hedge funds we track hold SYRE, worth $1.11B combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 10 opened a new position, 7 added, 2 trimmed, 3 exited.

12 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at SYRE · All tracked funds